Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: A randomized phase II, placebo-controlled trial

Hiroshi Nakase, Shuh Narumiya, Nobuhide Oshitani et al.|Inflammatory Bowel Diseases|2009

Cited by 54